Advertisement

Index by author

November 01, 1989; Volume 36,Issue 5

A

  1. Akiyama, S

    1. Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
      S Akiyama, A Yoshimura, H Kikuchi, T Sumizawa, M Kuwano and Y Tahara
      Molecular Pharmacology November 1989, 36 (5) 730-735;

B

  1. Beavo, J A

    1. Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948.
      P G Gillespie and J A Beavo
      Molecular Pharmacology November 1989, 36 (5) 773-781;

  2. Blättler, W A

    1. Cytotoxicity of gelonin conjugated to targeting molecules: effects of weak amines, monensin, adenovirus, and adenoviral capsid proteins penton, hexon, and fiber.
      V S Goldmacher, W A Blättler, J M Lambert, G McIntyre and J Stewart
      Molecular Pharmacology November 1989, 36 (5) 818-822;

  3. Blaustein, M P

    1. Rat brain dendrotoxin receptors associated with voltage-gated potassium channels: dendrotoxin binding and receptor solubilization.
      R G Sorensen and M P Blaustein
      Molecular Pharmacology November 1989, 36 (5) 689-698;

  4. Blumer, J L

    1. Role of microtubule assembly in phenytoin teratogenic action in the sea urchin (Arbacia punctulata) embryo.
      S Estus and J L Blumer
      Molecular Pharmacology November 1989, 36 (5) 708-715;

  5. Breuer, E

    1. Distance geometry of alpha-substituted 2,2-diphenylpropionate antimuscarinics.
      R K Gordon, E Breuer, F N Padilla, R M Smejkal and P K Chiang
      Molecular Pharmacology November 1989, 36 (5) 766-772;

C

  1. Chiang, P K

    1. Distance geometry of alpha-substituted 2,2-diphenylpropionate antimuscarinics.
      R K Gordon, E Breuer, F N Padilla, R M Smejkal and P K Chiang
      Molecular Pharmacology November 1989, 36 (5) 766-772;

  2. Collier, K

    1. Adenosine is required for ethanol-induced heterologous desensitization.
      L E Nagy, I Diamond, K Collier, L Lopez, B Ullman and A S Gordon
      Molecular Pharmacology November 1989, 36 (5) 744-748;

  3. Colman, P D

    1. Relative substrate activities of structurally related pteridine, quinazoline, and pyrimidine analogs for mouse liver folylpolyglutamate synthetase.
      R G Moran, P D Colman and T R Jones
      Molecular Pharmacology November 1989, 36 (5) 736-743;

D

  1. de Carvalho, M S

    1. Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation.
      K B Glaser, M S de Carvalho, R S Jacobs, M R Kernan and D J Faulkner
      Molecular Pharmacology November 1989, 36 (5) 782-788;

  2. Diamond, I

    1. Adenosine is required for ethanol-induced heterologous desensitization.
      L E Nagy, I Diamond, K Collier, L Lopez, B Ullman and A S Gordon
      Molecular Pharmacology November 1989, 36 (5) 744-748;

  3. Didsbury, J

    1. Modification of the rat adipocyte A1 adenosine receptor-adenylate cyclase system during chronic exposure to an A1 adenosine receptor agonist: alterations in the quantity of GS alpha and Gi alpha are not associated with changes in their mRNAs.
      J P Longabaugh, J Didsbury, A Spiegel and G L Stiles
      Molecular Pharmacology November 1989, 36 (5) 681-688;

E

  1. Eling, T

    1. Mechanism of inhibition of prostaglandin H synthase by eugenol and other phenolic peroxidase substrates.
      D Thompson and T Eling
      Molecular Pharmacology November 1989, 36 (5) 809-817;

  2. Estus, S

    1. Role of microtubule assembly in phenytoin teratogenic action in the sea urchin (Arbacia punctulata) embryo.
      S Estus and J L Blumer
      Molecular Pharmacology November 1989, 36 (5) 708-715;

F

  1. Faulkner, D J

    1. Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation.
      K B Glaser, M S de Carvalho, R S Jacobs, M R Kernan and D J Faulkner
      Molecular Pharmacology November 1989, 36 (5) 782-788;

  2. Funae, Y

    1. Suppression of hepatic levels of an ethanol-inducible P-450DM/j by growth hormone: relationship between the increased level of P-450DM/j and depletion of growth hormone in diabetes.
      Y Yamazoe, N Murayama, M Shimada, S Imaoka, Y Funae and R Kato
      Molecular Pharmacology November 1989, 36 (5) 716-722;

G

  1. Gillespie, P G

    1. Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948.
      P G Gillespie and J A Beavo
      Molecular Pharmacology November 1989, 36 (5) 773-781;

  2. Glaser, K B

    1. Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation.
      K B Glaser, M S de Carvalho, R S Jacobs, M R Kernan and D J Faulkner
      Molecular Pharmacology November 1989, 36 (5) 782-788;

  3. Goldmacher, V S

    1. Cytotoxicity of gelonin conjugated to targeting molecules: effects of weak amines, monensin, adenovirus, and adenoviral capsid proteins penton, hexon, and fiber.
      V S Goldmacher, W A Blättler, J M Lambert, G McIntyre and J Stewart
      Molecular Pharmacology November 1989, 36 (5) 818-822;

  4. Gordon, A S

    1. Adenosine is required for ethanol-induced heterologous desensitization.
      L E Nagy, I Diamond, K Collier, L Lopez, B Ullman and A S Gordon
      Molecular Pharmacology November 1989, 36 (5) 744-748;

  5. Gordon, R K

    1. Distance geometry of alpha-substituted 2,2-diphenylpropionate antimuscarinics.
      R K Gordon, E Breuer, F N Padilla, R M Smejkal and P K Chiang
      Molecular Pharmacology November 1989, 36 (5) 766-772;

H

  1. Hinton, D E

    1. Cytochrome P450IA1 induction and localization in endothelium of vertebrate (teleost) heart.
      J J Stegeman, M R Miller and D E Hinton
      Molecular Pharmacology November 1989, 36 (5) 723-729;

I

  1. Imaoka, S

    1. Suppression of hepatic levels of an ethanol-inducible P-450DM/j by growth hormone: relationship between the increased level of P-450DM/j and depletion of growth hormone in diabetes.
      Y Yamazoe, N Murayama, M Shimada, S Imaoka, Y Funae and R Kato
      Molecular Pharmacology November 1989, 36 (5) 716-722;

J

  1. Jacobs, R S

    1. Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation.
      K B Glaser, M S de Carvalho, R S Jacobs, M R Kernan and D J Faulkner
      Molecular Pharmacology November 1989, 36 (5) 782-788;

  2. Jones, T R

    1. Relative substrate activities of structurally related pteridine, quinazoline, and pyrimidine analogs for mouse liver folylpolyglutamate synthetase.
      R G Moran, P D Colman and T R Jones
      Molecular Pharmacology November 1989, 36 (5) 736-743;

K

  1. Kato, R

    1. Suppression of hepatic levels of an ethanol-inducible P-450DM/j by growth hormone: relationship between the increased level of P-450DM/j and depletion of growth hormone in diabetes.
      Y Yamazoe, N Murayama, M Shimada, S Imaoka, Y Funae and R Kato
      Molecular Pharmacology November 1989, 36 (5) 716-722;

  2. Kernan, M R

    1. Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation.
      K B Glaser, M S de Carvalho, R S Jacobs, M R Kernan and D J Faulkner
      Molecular Pharmacology November 1989, 36 (5) 782-788;

  3. Kikuchi, H

    1. Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
      S Akiyama, A Yoshimura, H Kikuchi, T Sumizawa, M Kuwano and Y Tahara
      Molecular Pharmacology November 1989, 36 (5) 730-735;

  4. Krueger, B K

    1. Batrachotoxin and alpha-scorpion toxin stabilize the open state of single voltage-gated sodium channels.
      M E O'Leary and B K Krueger
      Molecular Pharmacology November 1989, 36 (5) 789-795;

  5. Kuwano, M

    1. Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
      S Akiyama, A Yoshimura, H Kikuchi, T Sumizawa, M Kuwano and Y Tahara
      Molecular Pharmacology November 1989, 36 (5) 730-735;

L

  1. Lambert, J M

    1. Cytotoxicity of gelonin conjugated to targeting molecules: effects of weak amines, monensin, adenovirus, and adenoviral capsid proteins penton, hexon, and fiber.
      V S Goldmacher, W A Blättler, J M Lambert, G McIntyre and J Stewart
      Molecular Pharmacology November 1989, 36 (5) 818-822;

  2. Lee, W

    1. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
      W Lee and B B Wolfe
      Molecular Pharmacology November 1989, 36 (5) 749-757;

  3. Longabaugh, J P

    1. Modification of the rat adipocyte A1 adenosine receptor-adenylate cyclase system during chronic exposure to an A1 adenosine receptor agonist: alterations in the quantity of GS alpha and Gi alpha are not associated with changes in their mRNAs.
      J P Longabaugh, J Didsbury, A Spiegel and G L Stiles
      Molecular Pharmacology November 1989, 36 (5) 681-688;

  4. Lopez, L

    1. Adenosine is required for ethanol-induced heterologous desensitization.
      L E Nagy, I Diamond, K Collier, L Lopez, B Ullman and A S Gordon
      Molecular Pharmacology November 1989, 36 (5) 744-748;

M

  1. McIntyre, G

    1. Cytotoxicity of gelonin conjugated to targeting molecules: effects of weak amines, monensin, adenovirus, and adenoviral capsid proteins penton, hexon, and fiber.
      V S Goldmacher, W A Blättler, J M Lambert, G McIntyre and J Stewart
      Molecular Pharmacology November 1989, 36 (5) 818-822;

  2. Miller, L G

    1. Chronic clonazepam administration decreases gamma-aminobutyric acidA receptor function in cultured cortical neurons.
      L G Miller, R B Roy and C L Weill
      Molecular Pharmacology November 1989, 36 (5) 796-802;

  3. Miller, M R

    1. Cytochrome P450IA1 induction and localization in endothelium of vertebrate (teleost) heart.
      J J Stegeman, M R Miller and D E Hinton
      Molecular Pharmacology November 1989, 36 (5) 723-729;

  4. Miller, R J

    1. Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: interaction with polyamines.
      I J Reynolds and R J Miller
      Molecular Pharmacology November 1989, 36 (5) 758-765;

  5. Moran, R G

    1. Relative substrate activities of structurally related pteridine, quinazoline, and pyrimidine analogs for mouse liver folylpolyglutamate synthetase.
      R G Moran, P D Colman and T R Jones
      Molecular Pharmacology November 1989, 36 (5) 736-743;

  6. Morgan, E T

    1. Suppression of constitutive cytochrome P-450 gene expression in livers of rats undergoing an acute phase response to endotoxin.
      E T Morgan
      Molecular Pharmacology November 1989, 36 (5) 699-707;

  7. Murayama, N

    1. Suppression of hepatic levels of an ethanol-inducible P-450DM/j by growth hormone: relationship between the increased level of P-450DM/j and depletion of growth hormone in diabetes.
      Y Yamazoe, N Murayama, M Shimada, S Imaoka, Y Funae and R Kato
      Molecular Pharmacology November 1989, 36 (5) 716-722;

N

  1. Nagy, L E

    1. Adenosine is required for ethanol-induced heterologous desensitization.
      L E Nagy, I Diamond, K Collier, L Lopez, B Ullman and A S Gordon
      Molecular Pharmacology November 1989, 36 (5) 744-748;

O

  1. O'Leary, M E

    1. Batrachotoxin and alpha-scorpion toxin stabilize the open state of single voltage-gated sodium channels.
      M E O'Leary and B K Krueger
      Molecular Pharmacology November 1989, 36 (5) 789-795;

  2. Ozawa, H

    1. Coupling of the stimulatory GTP-binding protein Gs to rat synaptic membrane adenylate cyclase is enhanced subsequent to chronic antidepressant treatment.
      H Ozawa and M M Rasenick
      Molecular Pharmacology November 1989, 36 (5) 803-808;

P

  1. Padilla, F N

    1. Distance geometry of alpha-substituted 2,2-diphenylpropionate antimuscarinics.
      R K Gordon, E Breuer, F N Padilla, R M Smejkal and P K Chiang
      Molecular Pharmacology November 1989, 36 (5) 766-772;

R

  1. Rasenick, M M

    1. Coupling of the stimulatory GTP-binding protein Gs to rat synaptic membrane adenylate cyclase is enhanced subsequent to chronic antidepressant treatment.
      H Ozawa and M M Rasenick
      Molecular Pharmacology November 1989, 36 (5) 803-808;

  2. Reynolds, I J

    1. Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: interaction with polyamines.
      I J Reynolds and R J Miller
      Molecular Pharmacology November 1989, 36 (5) 758-765;

  3. Roy, R B

    1. Chronic clonazepam administration decreases gamma-aminobutyric acidA receptor function in cultured cortical neurons.
      L G Miller, R B Roy and C L Weill
      Molecular Pharmacology November 1989, 36 (5) 796-802;

S

  1. Shimada, M

    1. Suppression of hepatic levels of an ethanol-inducible P-450DM/j by growth hormone: relationship between the increased level of P-450DM/j and depletion of growth hormone in diabetes.
      Y Yamazoe, N Murayama, M Shimada, S Imaoka, Y Funae and R Kato
      Molecular Pharmacology November 1989, 36 (5) 716-722;

  2. Smejkal, R M

    1. Distance geometry of alpha-substituted 2,2-diphenylpropionate antimuscarinics.
      R K Gordon, E Breuer, F N Padilla, R M Smejkal and P K Chiang
      Molecular Pharmacology November 1989, 36 (5) 766-772;

  3. Sorensen, R G

    1. Rat brain dendrotoxin receptors associated with voltage-gated potassium channels: dendrotoxin binding and receptor solubilization.
      R G Sorensen and M P Blaustein
      Molecular Pharmacology November 1989, 36 (5) 689-698;

  4. Spiegel, A

    1. Modification of the rat adipocyte A1 adenosine receptor-adenylate cyclase system during chronic exposure to an A1 adenosine receptor agonist: alterations in the quantity of GS alpha and Gi alpha are not associated with changes in their mRNAs.
      J P Longabaugh, J Didsbury, A Spiegel and G L Stiles
      Molecular Pharmacology November 1989, 36 (5) 681-688;

  5. Stegeman, J J

    1. Cytochrome P450IA1 induction and localization in endothelium of vertebrate (teleost) heart.
      J J Stegeman, M R Miller and D E Hinton
      Molecular Pharmacology November 1989, 36 (5) 723-729;

  6. Stewart, J

    1. Cytotoxicity of gelonin conjugated to targeting molecules: effects of weak amines, monensin, adenovirus, and adenoviral capsid proteins penton, hexon, and fiber.
      V S Goldmacher, W A Blättler, J M Lambert, G McIntyre and J Stewart
      Molecular Pharmacology November 1989, 36 (5) 818-822;

  7. Stiles, G L

    1. Modification of the rat adipocyte A1 adenosine receptor-adenylate cyclase system during chronic exposure to an A1 adenosine receptor agonist: alterations in the quantity of GS alpha and Gi alpha are not associated with changes in their mRNAs.
      J P Longabaugh, J Didsbury, A Spiegel and G L Stiles
      Molecular Pharmacology November 1989, 36 (5) 681-688;

  8. Sumizawa, T

    1. Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
      S Akiyama, A Yoshimura, H Kikuchi, T Sumizawa, M Kuwano and Y Tahara
      Molecular Pharmacology November 1989, 36 (5) 730-735;

T

  1. Tahara, Y

    1. Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
      S Akiyama, A Yoshimura, H Kikuchi, T Sumizawa, M Kuwano and Y Tahara
      Molecular Pharmacology November 1989, 36 (5) 730-735;

  2. Thompson, D

    1. Mechanism of inhibition of prostaglandin H synthase by eugenol and other phenolic peroxidase substrates.
      D Thompson and T Eling
      Molecular Pharmacology November 1989, 36 (5) 809-817;

U

  1. Ullman, B

    1. Adenosine is required for ethanol-induced heterologous desensitization.
      L E Nagy, I Diamond, K Collier, L Lopez, B Ullman and A S Gordon
      Molecular Pharmacology November 1989, 36 (5) 744-748;

W

  1. Weill, C L

    1. Chronic clonazepam administration decreases gamma-aminobutyric acidA receptor function in cultured cortical neurons.
      L G Miller, R B Roy and C L Weill
      Molecular Pharmacology November 1989, 36 (5) 796-802;

  2. Wolfe, B B

    1. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
      W Lee and B B Wolfe
      Molecular Pharmacology November 1989, 36 (5) 749-757;

Y

  1. Yamazoe, Y

    1. Suppression of hepatic levels of an ethanol-inducible P-450DM/j by growth hormone: relationship between the increased level of P-450DM/j and depletion of growth hormone in diabetes.
      Y Yamazoe, N Murayama, M Shimada, S Imaoka, Y Funae and R Kato
      Molecular Pharmacology November 1989, 36 (5) 716-722;

  2. Yoshimura, A

    1. Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
      S Akiyama, A Yoshimura, H Kikuchi, T Sumizawa, M Kuwano and Y Tahara
      Molecular Pharmacology November 1989, 36 (5) 730-735;
Back to top

In this issue

Advertisement